Gianluca Svegliati‐Baroni

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

Fabio Piscaglia, Gianluca Svegliati‐Baroni, Andrea Barchetti et al. · Hepatology · 2015 · 586 citations · Full text

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Paolo Caraceni, Oliviero Riggio, Paolo Angeli et al. · The Lancet · 2018 · 499 citations · Full text

Hepatology, Decompensated Cirrhosis, Liver Physiology +6

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro

Andrea Galli, David W. Crabb, E. Ceni et al. · Gastroenterology · 2002 · 434 citations

Fibrosis, Antidiabetic Thiazolidinediones, Medicine +9

Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study

M. Capanni, Francesca Calella, Maria Rosa Biagini et al. · Alimentary Pharmacology & Therapeutics · 2006 · 407 citations

Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis

Gianluca Svegliati‐Baroni, S. Saccomanno, C. Rychlicki et al. · Liver International · 2011 · 393 citations